Enhanced quality improvement (QI) programmes may be necessary to support the adoption of best practice in maternity units with less developed integrated working practices, a new paper published in the Journal Implementation Science suggests. The research builds on ARC West’s evaluation of the AHSN Network’s national PReCePT programme, led by the West of England AHSN, and the conduct of the nested PReCePT study.
Magnesium sulphate is a low-cost medicine given to women going into early labour to protect their babies’ brains. It reduces the risk of cerebral palsy by a third.
The national PReCePT programme supported maternity units in England to increase their use of magnesium sulphate for women in early labour. The programme aimed to increase use of magnesium sulphate by 2020 to 85% of eligible mothers, with a stretch target of 95% for high-performing units.
The paper compares the implementation outcomes from scaling up the PReCePT programme with either the standard QI package or an enhanced package, tested via the PReCePT study.
The researchers found that all units, irrespective of whether they received a standard or enhanced QI package, succeeded in restructuring their ways of working to enable them to administer magnesium sulphate.
However, sustaining the changes once resources such as the support offered through the PReCePT programme had been withdrawn, required additional implementation work.
The findings suggest that to sustain the benefits from such programmes, ‘relational restructuring’ was needed. This means that doctors and midwives had to work and communicate as a team and support each other to accommodate new workflows and facilitate the sharing of responsibilities and tasks in daily practice.
Relational restructuring was more likely to have been achieved in units receiving enhanced QI support but also happened in units with standard QI support, especially in those where perinatal team working was already well established.
These findings emphasise the importance of working beyond siloes and across teams in maternity units, chiming with the findings of the Ockenden report. Enhanced QI initiatives, modelled on PReCePT, could be one way of improving teamwork in maternity units where more multidisciplinary working is needed.
Karen Luyt, Professor of Neonatal Medicine at the University of Bristol and PReCePT clinical lead, said:
“In this large national qualitative study we identified that collaborative multi-professional / perinatal team working is the key factor in implementing and sustaining new maternity treatments to protect babies.
“The PReCePT enhanced QI model was effective in supporting multi-professional teams, challenged by division/weak collaboration, to sustain improved care. These findings are widely applicable to maternity units invested in improving outcomes for mothers and babies, providing an evidence base for future programmes bringing new treatments into routine clinical practice.”
Posted on June 28, 2023
News you may like
Cochrane review confirms magnesium sulphate can prevent cerebral palsy in premature babies
Giving women at risk of premature birth a simple magnesium sulphate infusion can prevent their babies from developing cerebral palsy, a recent Cochrane review has confirmed. To increase uptake of magnesium sulphate, the PReCePT programme was developed by Health Innovation West of England with University Hospitals Bristol and Weston. As a result of its regional…
Read more
Black Maternity Matters statement: CQC national review of maternity services in England 2022 to 2024
The Black Maternity Matters collaborative welcomes the Care Quality Commission (CQC) report on its national review of maternity services in England, 2022 to 2024. One of the report findings is that the CQC remains concerned about “the inherent inequalities in access to maternity services, experience and outcomes for women, and the safety risks this presents.” The…
Read more
Putting evidence into practice – supporting people at high risk of developing hypertension in pregnancy
Following our Evidence into Practice call earlier this year, we are delighted to announce the successful evidence-based innovation that will now receive our support for rollout across the wider West of England. From the 20 high-quality applications received, we have selected the outpatient hypertension pathway for women and birthing people at high risk of developing…
Read more
